中文版 | English

在结果中检索

HFCAS OpenIR
（本次检索基于用户作品认领结果）

浏览/检索结果: 共4条，第1-4条 帮助

限定条件        
已选(0)清除 条数/页：   排序方式：
Cardiotoxicity of Epidermal Growth Factor Receptor 2-Targeted Drugs for Breast Cancer 期刊论文
FRONTIERS IN PHARMACOLOGY, 2021, 卷号: 12
作者:  Yang, ZiYan;  Wang, Wei;  Wang, Xiaojia;  Qin, ZhiQuan
收藏  |  浏览/下载：65/0  |  提交时间：2022/01/10
cardiotoxicity  ErbB2  targeting drugs  breast cancer  therapy  
The distinct clinicopathological and prognostic implications of PIK3CA mutations in breast cancer patients from Central China 期刊论文
CANCER MANAGEMENT AND RESEARCH, 2019, 卷号: 11, 期号: 无, 页码: 1473-1492
作者:  Wu, Haibo;  Wang, Wei;  Du, Jun;  Li, Hong;  Wang, Huogang;  Huang, Liangliang;  Xiang, Hang;  Xie, Jing;  Liu, Xiaoli;  Li, Heng;  Lin, Wenchu
浏览  |  Adobe PDF(1845Kb)  |  收藏  |  浏览/下载：194/161  |  提交时间：2020/05/21
breast cancer  PIK3CA  clinicopathological characteristics  prognosis  
Discovery and characterization of a novel irreversible EGFR mutants selective and potent kinase inhibitor CHMFL-EGFR-26 with a distinct binding mode 期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 11, 页码: 18359-18372
作者:  Hu, Chen;  Wang, Aoli;  Wu, Hong;  Qi, Ziping;  Li, Xixiang;  Yan, Xiao-E;  Chen, Cheng;  Yu, Kailin;  Zou, Fengming;  Wang, Wenchao;  Wang, Wei;  Wu, Jiaxin;  Liu, Juan;  Wang, Beilei;  Wang, Li;  Ren, Tao;  Zhang, Shanchun;  Yun, Cai-Hong;  Liu, Jing;  Liu, Qingsong
浏览  |  Adobe PDF(6153Kb)  |  收藏  |  浏览/下载：183/48  |  提交时间：2018/07/04
Egfr  Egfrt790m  Nsclc  Kinase Inhibitors  Drug Resistance  
Discovery of a highly potent FLT3 kinase inhibitor for FLT3-ITD-positive AML 期刊论文
LEUKEMIA, 2016, 卷号: 30, 期号: 10, 页码: 2112-2116
作者:  Wu, H.;  Wang, A.;  Qi, Z.;  Li, X.;  Chen, C.;  Yu, K.;  Zou, F.;  Hu, C.;  Wang, W.;  Zhao, Z.;  Wu, J.;  Liu, J.;  Liu, X.;  Wang, L.;  Wang, W.;  Zhang, S.;  Stone, R. M.;  Galinsky, I. A.;  Griffin, J. D.;  Weinstock, D.;  Christodoulou, A.;  Wang, H.;  Shen, Y.;  Zhai, Z.;  Weisberg, E. L.;  Liu, J.;  Liu, Q.
浏览  |  Adobe PDF(1142Kb)  |  收藏  |  浏览/下载：111/71  |  提交时间：2017/11/21